Dimana Miteva

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

Maria Domenica Cappellini, Vip Viprakasit, Alì Taher et al. · New England Journal of Medicine · 2020 · 306 citations

Medicine, Hematology, Molecular Medicine +13

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study

Maria Domenica Cappellini, John B. Porter, Raffaella Origa et al. · Haematologica · 2018 · 90 citations · Full text

Medicine, Hematology, Pharmacology +15

Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial

Alì Taher, Maria Domenica Cappellini, Antonis Kattamis et al. · The Lancet Haematology · 2022 · 57 citations

Medicine, Hematology, Pharmacology +8

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

Uwe Platzbecker, Valeria Santini, Rami S. Komrokji et al. · Leukemia · 2023 · 19 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results

Maria Domenica Cappellini, John B. Porter, Raffaella Origa et al. · Blood · 2013 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +8